Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jul;22(1):790.
doi: 10.3892/etm.2021.10222. Epub 2021 May 21.

Anti-inflammatory role of curcumin in retinal disorders (Review)

Affiliations
Review

Anti-inflammatory role of curcumin in retinal disorders (Review)

Federica Franzone et al. Exp Ther Med. 2021 Jul.

Abstract

Curcumin [1,7-bis-(4-hydroxy-3-methoxyphenyl)-hepta-1,6-diene-3,5-dione], the main component of turmeric (Curcuma longa, a flowering plant of the ginger family, Zingiberaceae), is known to possess different pharmacological activities, particularly anti-inflammatory and antioxidant properties. Since an underlying inflammatory process exists in several ocular conditions, such as anterior uveitis, glaucoma, age-related macular degeneration (AMD) and diabetic retinopathy (DR), the aim of the present review was to summarize the pleiotropic effects exerted by this molecule, focusing in particular on its beneficial role in retinal diseases. The anti-inflammatory activity of curcumin has also been described in numerous systemic inflammatory pathologies and tumors. Specifically, the biological, pharmaceutical and nutraceutical properties of curcumin are associated with its ability to downregulate the expression of the following genes: IκBα, cyclooxygenase 2, prostaglandin E2, interleukin (IL)-1, IL-6, IL-8 and tumor necrosis factor-α. According to this finding, curcumin may be useful in the treatment of some retinal disorders. In DR, proliferative vitreoretinopathy and AMD, beneficial effects have been observed following treatment with curcumin, including slowing down of the inflammatory process. Despite the aforementioned evidence, the main disadvantage of this substance is that it possesses a low solubility, as well as poor oral bioavailability due to its reduced absorption, rapid metabolism and rapid elimination. Therefore, several curcumin analogues have been synthesized and tested over the years, in order to improve the possible obtainable therapeutic effects. The purpose of the present review was to identify new aspects that could guide future research on this important traditional medicine, which is a well-tolerated natural product, and is widely considered safe and economical.

Keywords: DR; ROS; curcumin; epidermal growth factor; polymeric micelles; protein kinases.

PubMed Disclaimer

Conflict of interest statement

DAS is the Editor-in-Chief for the journal, but had no personal involvement in the reviewing process, or any influence in terms of adjudicating on the final decision, for this article. The other authors declare that they have no competing interests.

Figures

Figure 1
Figure 1
Curcuma longa. (A) Turmeric flowers, (B) root and (C) its chemical structure.
Figure 2
Figure 2
OCT. Wet age-related macular degeneration with choroidal neovascularization. Subretinal fluid and fibrovascular pigment epithelial detachment were also evident on the OCT. Diagnostic images provided by Professor M. Nebbioso. OCT, optical coherence tomography.
Figure 3
Figure 3
OCT. Diabetic retinopathy with cystoid macular edema. OCT showed a retinal section with cystic spaces at the macula. Diagnostic images provided by Professor M. Nebbioso. OCT, optical coherence tomography.

Similar articles

Cited by

References

    1. López-Malo D, Villarón-Casares CA, Alarcón-Jiménez J, Miranda M, Díaz-Llopis M, Romero FJ, Villar VM. Curcumin as a Therapeutic Option in Retinal Diseases. Antioxidants. 2020;9(48) doi: 10.3390/antiox9010048. - DOI - PMC - PubMed
    1. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: Problems and promises. Mol Pharm. 2007;4:807–818. doi: 10.1021/mp700113r. - DOI - PubMed
    1. Peddada KV, Brown A, Verma V, Nebbioso M. Therapeutic potential of curcumin in major retinal pathologies. Int Ophthalmol. 2019;39:725–734. doi: 10.1007/s10792-018-0845-y. - DOI - PubMed
    1. Noorafshan A, Ashkani-Esfahani S. A review of therapeutic effects of curcumin. Curr Pharm Des. 2013;19:2032–2046. - PubMed
    1. Deogade SC, Ghate S. Curcumin: Therapeutic applications in systemic and oral health. Int J Biol Pharm Res. 2015;6:281–290.